Morphine exposure and neurodevelopmental outcome in infants born extremely preterm
Developmental Medicine & Child Neurology · 2023-08 · 65 (8) · 1053-1060
DOI: 10.1111/dmcn.15510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 17.01.2023. Verfasst von Michele Luzzati und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Infant, Extremely Premature, Child Development. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aim
To investigate the association between morphine exposure in the neonatal period and neurodevelopment at 2 and 5 years of age while controlling for potential confounders.
Method
We performed a retrospective, single‐centre cohort study on 106 infants (60 males, 46 females; mean gestational age 26 weeks [SD 1]) born extremely preterm (gestational age < 28 weeks). Morphine administration was expressed as cumulative dose (mg/kg) until term‐equivalent age. Neurodevelopmental outcome was assessed at 2 years with the Bayley Scales of Infant and Toddler Development, Third Edition, Dutch version and at 5 years with the Wechsler Preschool and Primary Scale of Intelligence, Third Edition, Dutch version. Multiple linear regression analysis was used to assess the association between morphine exposure and outcome.
Results
Sixty‐four out of 106 (60.4%) infants included in the study received morphine. Morphine exposure was not associated with poorer motor, cognitive, and language subscores of the Bayley Scales of Infant and Toddler Development, Third Edition, Dutch version at 2 years. Morphine exposure was associated with lower Full‐Scale IQ scores ( p = 0.008, B = −9.3, 95% confidence interval [CI] = −15.6 to −3.1) and Performance IQ scores ( p = 0.005, B = −17.5, 95% CI = −27.9 to −7) at 5 years of age.
Interpretation
Morphine exposure in infants born preterm is associated with poorer Full‐Scale IQ and Performance IQ at 5 years. Individualized morphine administration is advised in infants born extremely preterm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
- Division of Neonatology, University of Florence, Florence, Italy.
- Department of Neonatology, Division of Perinatology and Gynecology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
ORCID-Profile: Caterina Coviello
Zitieren
APA
Luzzati, M., Coviello, C., De Veye, H. S., Dudink, J., Lammertink, F., Dani, C., Koopmans, C., Benders, M., & Tataranno, M. L. (2023). Morphine exposure and neurodevelopmental outcome in infants born extremely preterm. Developmental Medicine & Child Neurology, 65(8), 1053-1060. https://doi.org/10.1111/dmcn.15510
Vancouver
Luzzati M, Coviello C, De Veye HS, Dudink J, Lammertink F, Dani C, et al. Morphine exposure and neurodevelopmental outcome in infants born extremely preterm. Developmental Medicine & Child Neurology. 2023;65(8):1053-1060. doi:10.1111/dmcn.15510
BibTeX
@article{Luzzati2023,
author = {Luzzati, Michele and Coviello, Caterina and De Veye, Henriette Swarenburg and Dudink, Jeroen and Lammertink, Femke and Dani, Carlo and Koopmans, Corine and Benders, Manon and Tataranno, Maria Luisa},
title = {Morphine exposure and neurodevelopmental outcome in infants born extremely preterm},
journal = {Developmental Medicine & Child Neurology},
year = {2023},
volume = {65},
number = {8},
pages = {1053--1060},
doi = {10.1111/dmcn.15510}
}
EUVIMED